A pharmacokinetic model for chromium.
Reduction of hexavalent chromium (Cr(VI) to trivalent chromium (Cr(III) and differential kinetics of Cr(III) and Cr(VI) are important determinants of the disposition and toxicity of chromium. A physiologically based model of chromium disposition in the rat has been developed. The model takes into account different absorption and reduction rates in the lung and gastrointestinal tract; different efficiencies of transfer of Cr(III) and Cr(VI) into tissues including erythrocytes, where Cr(VI) is reduced to Cr(III) and retained for an extended period of time; uptake and storage in bone; and reabsorption of chromium from the gastrointestinal tract. The model is shown to be capable of generating the observed distributions of chromium between plasma and erythrocytes in rats given Cr(VI) intragastrically, intraduodenally, or intratracheally.